SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Kfir Azoulay, vice president and head of corporate strategy at Heidelberg Engineering, discusses the Spectralis imaging platform.
Author: Healio ophthalmology
Study quantifies stress of surgeons with different levels of experience
BELGRADE, Serbia — Quantification of surgical stress showed how experience affects emotional control and physiological parameters such as heart rate and breathing rate. Also, in beginner surgeons, stress progressively decreases throughout the day as they perform subsequent operations.
At the Hanusch Hospital in Vienna, a study was performed to assess stress levels of both patients and surgeons during cataract procedures. The Neuromaster system was used to measure stress parameters such as sweating, heart rate and respiration.
“In patients, we could see that stress level was reduced
Corneal lenticules from ReLEx SMILE can be used to treat corneal ulcers
BELGRADE, Serbia — Corneal lenticules, which are a waste product of ReLEx small incision lenticule extraction, could be used as an alternative method to treat corneal ulcers, according to one speaker.
“The treatment of corneal ulcers is difficult, and in some cases we have to use surgical interventions such as amniotic membrane transplantation or even keratoplasty,” Pavel Studeny, MD, said at the European Society of Cataract and Refractive Surgeons winter meeting.
He showed at the meeting three cases in which a ReLEx SMILE corneal lenticule from a donor was transplanted (Read more...)
VIDEO: MicroPulse technology reduces IOP in wide range of glaucomatous eyes
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Shan Lin, MD, talks about a study he and colleagues at UCSF have initiated, using Iridex’s MicroPulse laser technology in transscleral cyclophotocoagulation in patients with a range of mild to refractory glaucoma. The technology has so far successfully lowered IOP 20% or more in 68% of eyes treated, he said.
Specialist gives pearls on how to deal with traumatic cataract
BELGRADE, Serbia — Cataract surgery has a low complication rate and is the most common, highly standardized procedure in the world, but there are no rules or pre-established patterns when cataract occurs in a traumatized eye.
“Traumatic cataract is another operation entirely. In trauma cases, there is no limits to what might happen and what might be needed, and this includes temporary keratoprosthesis with a complete mess inside the eye,” Ferenc Kuhn, MD, said at the European Society of Cataract and Refractive Surgeons winter meeting. “If you don’t plan your
Study shows advantages of femtosecond laser-assisted cataract surgery
BELGRADE, Serbia — Femtosecond laser-assisted cataract surgery with the Femto LDV Z8 laser from Ziemer offers the advantages of repeatable and precise outcomes, best placement of the capsulotomy and optimized surgical planning with the patient in one position from the beginning to end of surgery, according to one speaker.
“The operating time and workflow can be optimized and continuously improve with experience. We are now able to perform four to five FLACS per hour,” Brigitte Pajic-Eggspuehler, MD, said at the European Society of Cataract and Refractive Surgeons winter
Internationally esteemed ophthalmologist Benjamin F. Boyd, MD, FACS, dies
Author, educator and internationally esteemed ophthalmologist Benjamin F. Boyd, MD, FACS, of Panama died Feb. 5.The announcement was posted to the Facebook page of the Boyd Clinic in Panama City, the practice Boyd founded in 1954 and which currently in…
VIDEO: Glaucoma 360 highlights innovation in glaucoma
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, co-chairs of Glaucoma 360, discuss innovations presented at the meeting and the 3 days of events that comprise the conference.
Early results with hyperopic SMILE show promise
BELGRADE, Serbia — Early results with hyperopic ReLEx small incision lenticule extraction, presented at the European Society of Cataract and Refractive Surgeons winter meeting, seem promising, according to one of the multicenter study investigators.
“Hyperopic correction of the cornea is more challenging than myopia; therefore, it took a few years for SMILE to get ready for this. Results are very promising, though we need to assess stability in the long term because we ablate quite a high amount of tissue,” Pavel Stodulka, MD, said.
A negative lenticule is created, thinner (Read more...)
Early results with hyperopic SMILE show promise
BELGRADE, Serbia — Early results with hyperopic ReLEx small incision lenticule extraction, presented at the European Society of Cataract and Refractive Surgeons winter meeting, seem promising, according to one of the multicenter study investigators.
“Hyperopic correction of the cornea is more challenging than myopia; therefore, it took a few years for SMILE to get ready for this. Results are very promising, though we need to assess stability in the long term because we ablate quite a high amount of tissue,” Pavel Stodulka, MD, said.
A negative lenticule is created, thinner (Read more...)
DACA: Losing one ‘dreamer’ in medical school ‘can have a huge impact’ on patient care
Mark G. KuczewskiAs the government debates immigration and the fate of the Deferred Action for Childhood Arrivals, medical schools envision the possible implications for students who are protected from deportation and allowed to work despite arriving i…
DMEK does not alter corneal biomechanics
BELGRADE, Serbia — Unlike Descemet’s stripping endothelial keratoplasty, Descemet’s membrane endothelial keratoplasty does not alter the biomechanical properties of the cornea, according to a study presented here at the European Society of Cataract and Refractive Surgeons winter meeting.
“DSEK transplants additional stromal tissue in the eye, while in DMEK there is a 1:1 replacement. This basic difference may not only affect corneal physiology, but also have practical consequences on the reliability of IOP measurements, for instance,” Natalya Shilova, MD, said.
The
DMEK does not alter corneal biomechanics
BELGRADE, Serbia — Unlike Descemet’s stripping endothelial keratoplasty, Descemet’s membrane endothelial keratoplasty does not alter the biomechanical properties of the cornea, according to a study presented here at the European Society of Cataract and Refractive Surgeons winter meeting.
“DSEK transplants additional stromal tissue in the eye, while in DMEK there is a 1:1 replacement. This basic difference may not only affect corneal physiology, but also have practical consequences on the reliability of IOP measurements, for instance,” Natalya Shilova, MD, said.
The
Topline data suggest bioactivity for carotuximab in refractory wet AMD
Topline results from a phase 1/2 study of DE-122 suggest bioactivity of the agent in cases of refractory wet age-related macular degeneration, according to a press release from Santen.The data were presented at Angiogenesis, Exudation, and Degeneration…
VIDEO: Aerie ramps up marketing for Rhopressa
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses the build-out the company is performing to ramp up for the commercial launch of Rhopressa for the treatment of glaucoma and gives an update on clinical trials of Roclatan.
Low-energy femtosecond laser-assisted IOL fragmentation shows feasibility
BELGRADE, Serbia — Femtosecond laser-assisted IOL fragmentation using low energy parameters showed feasibility in a study presented at the European Society of Cataract and Refractive Surgeons winter meeting.
“There have been previous case reports, but the use of high energy and small spot produced excessive cavitation gas bubbles and production of toxic elements. Our purpose was to optimize energy parameters and verify the technique in the clinic,” Natalia Anisimova, MD, said.
Natalia Anisimova
Three hydrophobic lenses were previously dissected with variable energy between 1 µJ
Purdue Pharma ceases promotion of OxyContin to doctors
Purdue Pharma, the manufacturer of OxyContin, will stop promoting the drug to doctors, USA Today reported. The move comes in the wake of numerous lawsuits charging that the drug company is a major contributor to the national opioid epidemic.
Purdue reportedly released a statement on Feb. 10 that it would no longer send sales representatives to market the opioid painkiller at doctor’s offices, and that it would significantly reduce its sales force in accordance with the new policy.
The decision prompted the company to eliminate more than half of Purdue (Read more...)
VIDEO: nGoggle allows assessment of brain function using virtual reality
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Felipe Medeiros, MD, PhD, professor of ophthalmology at Duke University, discusses the development of the nGoggle, a device that merges virtual reality goggle technology with electroencephalogram technology to help assess visual function.
Bispecific antibody targets VEGF-A, angiopoietin-2 in DME
Jason EhrlichThe bispecific monoclonal antibody RG7716, which binds to and inactivates both VEGF-A and angiopoietin-2, met its primary endpoint of significant improvement in best corrected visual acuity compared with ranibizumab treatment in a phase 2 …
VIDEO: New class of therapies may offer neuroprotection, pressure lowering
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at the Byers Eye Institute at Stanford University, discusses new glaucoma therapies that show promise to not only lower IOP but also provide neuroprotection.